ADRA2A GENOTYPE IS NOT A PREDICTOR OF DEXMEDETOMIDINE DOSE IN CRITICALLY ILL PEDIATRIC PATIENTS.

Gallaway, K; Skaar, T; Biju, A; Slaven, J; Tillman, E

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022; 111 (): S21